UPDATE : Tuesday, November 19, 2019
상단여백
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab by Jeong Sae-im 2019-11-19 17:18
‘Udenafil improved exercise in single ventricle heart disease’ by Jeong Sae-im 2019-11-18 14:48
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment” by Kim Yun-mi 2019-11-15 17:48
Ministry revokes Kolon Life Science’s innovative drug company status by Lee Han-soo 2019-11-15 17:26
AbbVie presents new data for ankylosing spondylitis treatment in US by Lee Han-soo 2019-11-15 11:40
라인
Merck Korea wins award for helping families with infertility problems by Lee Han-soo 2019-11-14 18:05
Prosecutors raid drugmakers, distributors for suspected bid-rigging by Jeong Sae-im 2019-11-14 15:27
‘Novartis’ Kymriah takes one step closer to cancer cure’ by Lee Han-soo 2019-11-14 13:24
iCure to apply for testing incrementally modified cancer drugs in US by Lee Han-soo 2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam by Lee Han-soo 2019-11-13 16:52
라인
‘Generic drugs must indicate ingredient names on label’ by Kim Yun-mi 2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US by Lee Han-soo 2019-11-12 14:09
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis by Lee Han-soo 2019-11-11 18:02
Genexine’s new immunotherapy shows stability even in high dose by Jeong Sae-im 2019-11-11 13:36
Medpacto releases trial results at US conference by Lee Han-soo 2019-11-11 13:27
라인
Yuhan, Cyclica to co-develop new drugs by Lee Han-soo 2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off by Kim Yun-mi 2019-11-07 16:10
‘One-third of heart attack survivors overlook risk of recurrence’ by Lee Han-soo 2019-11-06 16:34
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis by Kim Yun-mi 2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug by Lee Han-soo 2019-11-06 15:57
여백
여백
여백
Back to Top